The International Market for Re-load®'s Nutraload™ Stem Cell product is over 3 times the original estimate

The International Market for Re-load®'s Nutraload™ Stem Cell product is over 3 times the original estimate

/* Style Definitions */
span.prnews_span
{
font-size:8pt;
font-family:"Arial";
color:black;
}
a.prnews_a
{
color:blue;
}
li.prnews_li
{
font-size:8pt;
font-family:"Arial";
color:black;
}
p.prnews_p
{
font-size:0.62em;
font-family:"Arial";
color:black;
margin:"0in";
}

PR Newswire

LAS VEGAS, July 15, 2013

LAS VEGAS, July 15, 2013 /PRNewswire/ -- CleanPath Resources Corp's (OTC Pink: CLNP) (www.re-load.biz and www.nutraload.com) internal estimates of the potential international market for its stem cell enhancing product Nutraload™ are over 3 times the original estimates and still growing.

More and more people around the world have come to recognize the incredible benefits resulting from having their bodies naturally increase the number of circulating stem cells. This awareness is increasing the market for Nutraload™. Nutraload™, CleanPath's proprietary patent pending stem cell enhancing nutraceutical, has been shown to help increase circulating stem cells by as much as 50% in as little as two hours

This significant increase in available stem cells aids the body in the ongoing repair and replacement process that keeps the body in good working order and helps us all to feel younger and better. Ken Lewis, Cleanpath's CEO stated, "This internal research shows the world is waking up to the benefits of naturally increasing the body's own stem cells and increasing the body's ability to maintain and improve its self. It is gratifying to see more and more people around the world recognizing and seeking the benefits of Nutraload™."

Contact: Ken Lewis, 877-309-9876

SOURCE CleanPath Resources Corp

Nova Tech Enterprises (PK) (USOTC:NTEI)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024